학술논문

Eligibility and Rate of Treatment for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Using Different Criteria.
Document Type
Article
Source
Academic Emergency Medicine; Mar2011, Vol. 18 Issue 3, p273-278, 6p, 1 Diagram, 4 Charts
Subject
CEREBROVASCULAR disease diagnosis
RECOMBINANT proteins
ANALYSIS of variance
CEREBROVASCULAR disease
CHI-squared test
COMPARATIVE studies
COMPUTER software
CONFIDENCE intervals
EMERGENCY medical services
FISHER exact test
LONGITUDINAL method
HEALTH outcome assessment
PROBABILITY theory
STATISTICAL hypothesis testing
T-test (Statistics)
DECISION making in clinical medicine
TISSUE plasminogen activator
ELIGIBILITY (Social aspects)
DATA analysis
RETROSPECTIVE studies
SEVERITY of illness index
THERAPEUTICS
Language
ISSN
10696563
Abstract
Copyright of Academic Emergency Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)